Nilesh Patel
Director/Miembro de la Junta en Cellanyx Diagnostics LLC .
Perfil
Nilesh Patel is currently working as a Director at Cellanyx Diagnostics LLC.
He completed his undergraduate degree from Indian Institute of Technology Bombay and his MBA from Columbia Business School.
Cargos activos de Nilesh Patel
| Empresas | Cargo | Inicio |
|---|---|---|
Cellanyx Diagnostics LLC
 Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Director/Miembro de la Junta | 19/01/2021 |
Formación de Nilesh Patel.
| Columbia Business School | Masters Business Admin |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Cellanyx Diagnostics LLC
Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Health Technology |
- Bolsa de valores
- Insiders
- Nilesh Patel
